Summary Keywords endocrinology, growth hormone secretagogues, IGF-1 analogues, off-label use, peptide hormones, performance-enhancing drugs, sports doping Citation Dominikowski A, Rko Z, Olejarz M, Szczepanek-Parulska E, Domin R and Ruchaa M (2026) The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration
The result is the volume, in mL, that needs to be drawn up to deliver that dose
Both groups also received lifestyle counseling
et al., 2022), conducted a screening of phenazine library compounds targeting breast cancer stem cells and identified three compounds (CPUL119, CPUL129, and CPUL149)
At Stellar Performance Medical, programs begin with a full assessment and may include nutrition guidance and supportive therapies
However, compared with small-molecule GLP-1 drugs such as Orforglipron, oral semaglutide remains a peptide-based therapy